InvestSMART

Botanix Pharmaceuticals Ltd (ASX: BOT) - Announcements

Current share price for BOT : $0.009 0.001 (10%)+

ASX company news and announcements for Botanix Pharmaceuticals Ltd (BOT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Botanix Pharmaceuticals Ltd (BOT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Botanix Pharmaceuticals Ltd (BOT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Botanix Pharmaceuticals Ltd (BOT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Botanix Presents at International Cannabinoid Summit 14 Dec 2018 9:27AM $0.070 $0.009 fallen by 87.14%
$25 Appendix 3B 6 Dec 2018 9:22AM $0.077 $0.009 fallen by 88.31%
$25 Investor Presentation 5 Dec 2018 9:53AM $0.079 $0.009 fallen by 88.61%
$25 Botanix receives A$4.6m R&D Tax Incentive refund 23 Nov 2018 8:35AM $0.077 $0.009 fallen by 88.31%
$25 Investor Presentation 15 Nov 2018 9:35AM $0.080 $0.009 fallen by 88.75%
$25 First Patient Treated in BTX 1308 Psoriasis Patient Study 7 Nov 2018 9:40AM $0.086 $0.009 fallen by 89.53%
$25 Appendix 4C - Quarterly 31 Oct 2018 6:52PM $0.080 $0.009 fallen by 88.75%
$25 Notice of Annual General Meeting/Proxy Form 19 Oct 2018 5:56PM $0.089 $0.009 fallen by 89.89%
$25 Botanix Presents at Fall Clinical Dermatology Conference 19 Oct 2018 9:31AM $0.089 $0.009 fallen by 89.89%
$25 Ethics Approval for BTX 1308 Psoriasis Patient Study Secured 27 Sep 2018 9:11AM $0.100 $0.009 fallen by 91%
$25 Appendix 4G 21 Sep 2018 4:50PM $0.100 $0.009 fallen by 91%
$25 Annual Report to shareholders 21 Sep 2018 4:45PM $0.100 $0.009 fallen by 91%
$25 Botanix presents at European Dermatology Conference 13 Sep 2018 9:22AM $0.096 $0.009 fallen by 90.63%
$25 Botanix BTX 1503 Clinical Trial Update 12 Sep 2018 10:37AM $0.096 $0.009 fallen by 90.63%
$25 Pause in trading 12 Sep 2018 9:58AM $0.096 $0.009 fallen by 90.63%
$25 Preliminary Final Report 31 Aug 2018 9:53AM $0.105 $0.009 fallen by 91.43%
$25 FDA Clears Development Path for BTX 1204 30 Aug 2018 9:28AM $0.105 $0.009 fallen by 91.43%
$25 Updated Investor Presentation Revised 13 Aug 2018 10:25AM $0.100 $0.009 fallen by 91%
$25 Updated Investor Presentation 13 Aug 2018 9:22AM $0.100 $0.009 fallen by 91%
$25 Appendix 4C - Quarterly 31 Jul 2018 9:18AM $0.105 $0.009 fallen by 91.43%
$25 Botanix Expands Clinical Capabilities 27 Jul 2018 9:17AM $0.100 $0.009 fallen by 91%
$25 Investigators Meeting Completed for BTX 1503 Phase 2 Trial 23 Jul 2018 9:34AM $0.100 $0.009 fallen by 91%
$25 Botanix Joins with UQ to Accelerate Development of BTX 1801 19 Jul 2018 9:35AM $0.100 $0.009 fallen by 91%
$25 Appendix 3B 16 Jul 2018 6:36PM $0.097 $0.009 fallen by 90.72%
$25 Botanix update on development pipeline products 2 Jul 2018 8:28AM n/a $0.009 n/a

576 - 600 of 726 results

Page 24 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.